Verdicts genuinely change. Free email alert the moment ETIHX's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Eventide Healthcare & Life Sciences Fund · MUTUAL FUND SERIES TRUST
93 holdings
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 101% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT At least 24.10% of portfolio weight is in non-compliant holdings — already over the 5% threshold, so the verdict is settled whatever the unmatched 56% turns out to be. Matching more holdings can only raise this share, never lower it.
93 holdings, 34 matched (45% of weight). Portfolio as of 2026-06-30, filed 2026-08-31. Source: SEC Form N-PORT.
17.87% of this portfolio’s income is non-permissible — weighted across holdings, computed over 37% of portfolio weight (27 of 93 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| GH GUARDANT HEALTH INC | COMPLIANT | 5.37% | AAOIFI7.8% Usmani88.7% Dow Jones Islamic17.9% S&P Shariah23.1% MSCI Islamic88.7% MSCI Islamic M-Series23.1% FTSE Shariah78.6% |
| US BANK MMDA | UNSCREENED | 3.75% | no in-house ratios for this holding |
| MIRM MIRUM PHARMACEUTICALS INC | COMPLIANT | 3.47% | AAOIFI11.6% Usmani73.0% Dow Jones Islamic20.3% S&P Shariah25.7% MSCI Islamic73.0% MSCI Islamic M-Series25.7% FTSE Shariah71.8% |
| KYMR KYMERA THERAPEUTICS INC | NON_COMPLIANT | 3.22% | AAOIFI0.8% Usmani4.8% Dow Jones Islamic1.7% S&P Shariah2.1% MSCI Islamic4.6% MSCI Islamic M-Series2.1% FTSE Shariah0.0% |
| ABIVAX SA | UNSCREENED | 2.94% | no in-house ratios for this holding |
| BeLite Bio Inc | UNSCREENED | 2.83% | no in-house ratios for this holding |
| TREVI THERAPEUTICS INC | UNSCREENED | 2.77% | no in-house ratios for this holding |
| MBX BIOSCIENCES INC | UNSCREENED | 2.70% | no in-house ratios for this holding |
| VAXCYTE INC | UNSCREENED | 2.69% | no in-house ratios for this holding |
| CYTK CYTOKINETICS INC | NON_COMPLIANT | 2.69% | AAOIFI3.9% Usmani20.7% Dow Jones Islamic5.9% S&P Shariah6.2% MSCI Islamic20.7% MSCI Islamic M-Series6.2% FTSE Shariah14.3% |
| ARGX ARGENX SE | COMPLIANT | 2.55% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| IONS IONIS PHARMACEUTICALS INC | NON_COMPLIANT | 2.55% | AAOIFI21.0% Usmani67.5% Dow Jones Islamic23.0% S&P Shariah25.1% MSCI Islamic67.5% MSCI Islamic M-Series25.1% FTSE Shariah58.8% |
| INSMED INC | UNSCREENED | 2.40% | no in-house ratios for this holding |
| REVOLUTION MEDICINES INC | UNSCREENED | 2.36% | no in-house ratios for this holding |
| AVALYN PHARMA INC | UNSCREENED | 2.35% | no in-house ratios for this holding |
| IMMX IMMIX BIOPHARMA INC | NON_COMPLIANT | 2.24% | AAOIFI0.1% Usmani0.4% Dow Jones Islamic0.4% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| CELLDEX THERAPEUTICS INC | UNSCREENED | 2.16% | no in-house ratios for this holding |
| PALVELLA THERAPEUTICS INC | UNSCREENED | 1.98% | no in-house ratios for this holding |
| KMTS KESTRA MEDICAL TECHNOLOGIES LTD | NON_COMPLIANT | 1.95% | AAOIFI5.2% Usmani22.0% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic22.0% MSCI Islamic M-Seriesfail FTSE Shariah20.9% |
| SCHOLAR ROCK HOLDING CORP | UNSCREENED | 1.95% | no in-house ratios for this holding |
| APOGEE THERAPEUTICS INC | UNSCREENED | 1.93% | no in-house ratios for this holding |
| DEFINIUM THERAPEUTICS INC | UNSCREENED | 1.87% | no in-house ratios for this holding |
| IRTC IRHYTHM HOLDINGS INC | COMPLIANT | 1.85% | AAOIFI17.9% Usmani66.5% Dow Jones Islamic17.8% S&P Shariah19.6% MSCI Islamic66.5% MSCI Islamic M-Series19.6% FTSE Shariah59.5% |
| BBIO BRIDGEBIO PHARMA INC | COMPLIANT | 1.82% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| BETA BIONICS INC | UNSCREENED | 1.80% | no in-house ratios for this holding |
| NRIX NURIX THERAPEUTICS INC | NON_COMPLIANT | 1.76% | AAOIFI2.1% Usmani10.9% Dow Jones Islamic4.1% S&P Shariah5.0% MSCI Islamic10.9% MSCI Islamic M-Series5.0% FTSE Shariah0.0% |
| ARWR ARROWHEAD PHARMACEUTICALS INC | COMPLIANT | 1.69% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| DISC MEDICINE INC | UNSCREENED | 1.62% | no in-house ratios for this holding |
| OVID OVID THERAPEUTICS INC | NON_COMPLIANT | 1.49% | AAOIFI2.3% Usmani5.5% Dow Jones Islamic8.0% S&P Shariah7.3% MSCI Islamic5.5% MSCI Islamic M-Series7.3% FTSE Shariah0.0% |
| CG ONCOLOGY INC | UNSCREENED | 1.46% | no in-house ratios for this holding |
| AMYLYX PHARMACEUTICALS INC | UNSCREENED | 1.33% | no in-house ratios for this holding |
| ORUKA THERAPEUTICS INC | UNSCREENED | 1.28% | no in-house ratios for this holding |
| FIRST AMERICAN FUNDS INC | UNSCREENED | 1.25% | no in-house ratios for this holding |
| DIANTHUS THERAPEUTICS INC | UNSCREENED | 1.23% | no in-house ratios for this holding |
| SIONNA THERAPEUTICS INC | UNSCREENED | 1.17% | no in-house ratios for this holding |
| CELCUITY INC | UNSCREENED | 1.14% | no in-house ratios for this holding |
| GKOS GLAUKOS CORP | COMPLIANT | 1.11% | AAOIFI0.9% Usmani17.3% Dow Jones Islamic1.4% S&P Shariah1.5% MSCI Islamic10.0% MSCI Islamic M-Series1.5% FTSE Shariah6.2% |
| STRO SUTRO BIOPHARMA INC | NON_COMPLIANT | 1.09% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| PRVA PRIVIA HEALTH GROUP INC | NON_COMPLIANT | 1.06% | AAOIFI0.3% Usmani0.6% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic0.6% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| EYPT EYEPOINT INC | NON_COMPLIANT | 1.00% | AAOIFIfail Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| SPYRE THERAPEUTICS INC | UNSCREENED | 0.99% | no in-house ratios for this holding |
| HTFL HEARTFLOW INC | COMPLIANT | 0.98% | AAOIFI0.6% Usmani7.9% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic7.9% MSCI Islamic M-Seriespass FTSE Shariah0.0% |
| DXCM DEXCOM INC | COMPLIANT | 0.95% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| AKTIS ONCOLOGY INC | UNSCREENED | 0.91% | no in-house ratios for this holding |
| ACHIEVE LIFE SCIENCES INC | UNSCREENED | 0.81% | no in-house ratios for this holding |
| UTHR UNITED THERAPEUTICS CORP | NON_COMPLIANT | 0.80% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| N/A | UNSCREENED | 0.80% | no in-house ratios for this holding |
| AXSM AXSOME THERAPEUTICS INC | COMPLIANT | 0.77% | AAOIFI1.9% Usmani29.5% Dow Jones Islamic2.9% S&P Shariah3.5% MSCI Islamic27.6% MSCI Islamic M-Series3.5% FTSE Shariah24.7% |
| KLRA KAILERA THERAPEUTICS INC | NON_COMPLIANT | 0.76% | AAOIFI0.5% Usmani0.8% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.8% MSCI Islamic M-Series— FTSE Shariah0.0% |
| PRAXIS PRECISION MEDICINES INC | UNSCREENED | 0.72% | no in-house ratios for this holding |
| TNGX TANGO THERAPEUTICS INC | NON_COMPLIANT | 0.70% | AAOIFI0.8% Usmani3.0% Dow Jones Islamic2.2% S&P Shariah2.5% MSCI Islamic3.0% MSCI Islamic M-Series2.5% FTSE Shariah0.0% |
| EVMN EVOMMUNE INC | NON_COMPLIANT | 0.70% | AAOIFI1.7% Usmani2.9% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic2.5% MSCI Islamic M-Seriesfail FTSE Shariah0.0% |
| Kardium Inc. | UNSCREENED | 0.60% | no in-house ratios for this holding |
| ORIC ORIC PHARMACEUTICALS INC | COMPLIANT | 0.58% | AAOIFI0.3% Usmani0.8% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| BELITE BIO INC | UNSCREENED | 0.54% | no in-house ratios for this holding |
| BRIGHT MINDS BIOSCIENCES INC | UNSCREENED | 0.51% | no in-house ratios for this holding |
| ADLAI NORTYE LTD | UNSCREENED | 0.46% | no in-house ratios for this holding |
| KARDIGAN INC | UNSCREENED | 0.40% | no in-house ratios for this holding |
| RLMD RELMADA THERAPEUTICS INC | NON_COMPLIANT | 0.39% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| ADLAI NORTYE LTD | UNSCREENED | 0.36% | no in-house ratios for this holding |
| N/A | UNSCREENED | 0.34% | no in-house ratios for this holding |
| INHIBRX BIOSCIENCES INC | UNSCREENED | 0.33% | no in-house ratios for this holding |
| RLMD RELMADA THERAPEUTICS INC | NON_COMPLIANT | 0.33% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| TMDX TRANSMEDICS GROUP INC | NON_COMPLIANT | 0.31% | AAOIFI0.8% Usmani25.5% Dow Jones Islamic0.7% S&P Shariah0.8% MSCI Islamic1.8% MSCI Islamic M-Series0.8% FTSE Shariah1.4% |
| OVID OVID THERAPEUTICS INC | NON_COMPLIANT | 0.29% | AAOIFI2.3% Usmani5.5% Dow Jones Islamic8.0% S&P Shariah7.3% MSCI Islamic5.5% MSCI Islamic M-Series7.3% FTSE Shariah0.0% |
| InMed Pharma Inc | UNSCREENED | 0.28% | no in-house ratios for this holding |
| PFE PFIZER INC | NON_COMPLIANT | 0.24% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| FIDELITY COLCHESTER STREET TRUST | UNSCREENED | 0.21% | no in-house ratios for this holding |
| EVMN EVOMMUNE INC | NON_COMPLIANT | 0.20% | AAOIFI1.7% Usmani2.9% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic2.5% MSCI Islamic M-Seriesfail FTSE Shariah0.0% |
| OVID Ovid Therapeutics Inc | NON_COMPLIANT | 0.20% | AAOIFI2.3% Usmani5.5% Dow Jones Islamic8.0% S&P Shariah7.3% MSCI Islamic5.5% MSCI Islamic M-Series7.3% FTSE Shariah0.0% |
| AVALYN PHARMA INC | UNSCREENED | 0.18% | no in-house ratios for this holding |
| IDYA IDEAYA BIOSCIENCES INC | NON_COMPLIANT | 0.14% | AAOIFI0.8% Usmani2.2% Dow Jones Islamic1.2% S&P Shariah1.1% MSCI Islamic2.2% MSCI Islamic M-Series1.1% FTSE Shariah0.0% |
| FREENOME HOLDINGS, INC. | UNSCREENED | 0.13% | no in-house ratios for this holding |
| PELOTON THERAPEUTICS | UNSCREENED | 0.10% | no in-house ratios for this holding |
| PROMETHEUS BIOSCIENCES | UNSCREENED | 0.05% | no in-house ratios for this holding |
| CASMA THERAPEUTICS II | UNSCREENED | 0.04% | no in-house ratios for this holding |
| FLARE THERAPEUTICS INC | UNSCREENED | 0.02% | no in-house ratios for this holding |
| CASMA THERAPEUTICS | UNSCREENED | 0.02% | no in-house ratios for this holding |
| CASMA THERAPEUTICS | UNSCREENED | 0.02% | no in-house ratios for this holding |
| FLARE THERAPEUTICS INCORPORATED | UNSCREENED | 0.02% | no in-house ratios for this holding |
| FRNM Freenome | NON_COMPLIANT | 0.02% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariahfail MSCI Islamic0.0% MSCI Islamic M-Seriesfail FTSE Shariah0.0% |
| N/A | UNSCREENED | 0.01% | no in-house ratios for this holding |
| CASMA THERAPEUTICS II | UNSCREENED | 0.01% | no in-house ratios for this holding |
| CASMA THERAPEUTICS, INC. | UNSCREENED | 0.01% | no in-house ratios for this holding |
| BIOSPLICE THERAPEUTICS INC. SERIES C | UNSCREENED | 0.00% | no in-house ratios for this holding |
| GOLDFINCH BIOPHARMA INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| GOLDFINCH BIO B2 | UNSCREENED | 0.00% | no in-house ratios for this holding |
| BIOSPLICE THERAPEUTICS INC. | UNSCREENED | 0.00% | no in-house ratios for this holding |
| BIOSPLICE THERAPEUTICS | UNSCREENED | 0.00% | no in-house ratios for this holding |
| GOLDFINCH BIO INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| KOJIN THERAPEUTICS | UNSCREENED | 0.00% | no in-house ratios for this holding |
| GOLDFINCH BIOPHARMA INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| KOJIN THERAPEUTICS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 17 points of portfolio weight — 17.5% of it passes AAOIFI, 0.2% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 17.5% ratios fail on 19.7% 63.9% not rated under AAOIFI
ratios pass on 2.3% ratios fail on 29.1% 69.7% not rated under Usmani
ratios pass on 15.4% ratios fail on 21.0% 64.6% not rated under Dow Jones Islamic
ratios pass on 15.4% ratios fail on 20.8% 64.8% not rated under S&P Shariah
ratios pass on 0.2% ratios fail on 31.1% 69.7% not rated under MSCI Islamic
ratios pass on 15.4% ratios fail on 20.8% 64.8% not rated under MSCI Islamic M-Series
ratios pass on 1.2% ratios fail on 30.2% 69.7% not rated under FTSE Shariah
30 of 93 listed holdings carry our own per-methodology verdicts (45% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 25 (37% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| KYMR KYMERA THERAPEUTICS INC | 3.22% |
| CYTK CYTOKINETICS INC | 2.69% |
| IONS IONIS PHARMACEUTICALS INC | 2.55% |
| IMMX IMMIX BIOPHARMA INC | 2.24% |
| KMTS KESTRA MEDICAL TECHNOLOGIES LTD | 1.95% |
| NRIX NURIX THERAPEUTICS INC | 1.76% |
| OVID OVID THERAPEUTICS INC | 1.49% |
| STRO SUTRO BIOPHARMA INC | 1.09% |
| PRVA PRIVIA HEALTH GROUP INC | 1.06% |
| EYPT EYEPOINT INC | 1.00% |
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Eventide Healthcare & Life Sciences Fund (ETIHX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.
| Holding | Weight | Verdict |
|---|---|---|
| GHGUARDANT HEALTH INC | 5.37% | Compliant |
| US BANK MMDAnot matched to a ticker | 3.75% | Not screened |
| MIRMMIRUM PHARMACEUTICALS INC | 3.47% | Compliant |
| KYMRKYMERA THERAPEUTICS INC | 3.22% | Non-compliant |
| ABIVAX SAnot matched to a ticker | 2.94% | Not screened |
| BeLite Bio Incnot matched to a ticker | 2.83% | Not screened |
| TREVI THERAPEUTICS INCnot matched to a ticker | 2.77% | Not screened |
| MBX BIOSCIENCES INCnot matched to a ticker | 2.70% | Not screened |
| VAXCYTE INCnot matched to a ticker | 2.69% | Not screened |
| CYTKCYTOKINETICS INC | 2.69% | Non-compliant |
Top 10 of 93 holdings, 32.4% of the fund by weight. Every holding is screened, not only these.
The positions keeping this fund short of 100% compliant by weight.
Verdict history for ETIHX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
ℹ️ no compliance scan has run for 2 days - this is not a reading of today
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 26.90 | BUY |
| Stochastic %K (14) | 0.00 | BUY |
| CCI (20) | -156.98 | BUY |
| Williams %R (14) | -100.00 | BUY |
| MACD (12,26,9) | -0.31 | SELL |
| ROC (10) | -8.50 | SELL |
| Momentum (10) | -4.66 | SELL |
| EMA (10) | 52.62 | SELL |
| SMA (10) | 52.74 | SELL |
| EMA (20) | 54.14 | SELL |
| SMA (20) | 54.56 | SELL |
| EMA (30) | 55.10 | SELL |
| SMA (30) | 56.00 | SELL |
| EMA (50) | 55.90 | SELL |
| SMA (50) | 57.61 | SELL |
| EMA (100) | 55.58 | SELL |
| SMA (100) | 55.94 | SELL |
| EMA (200) | 53.65 | SELL |
| SMA (200) | 53.58 | SELL |
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.